Published in Ann Surg on April 01, 1992
Balance of inflammatory cytokines related to severity and mortality of murine sepsis. Infect Immun (1996) 2.43
Interleukin-6 in the injured patient. Marker of injury or mediator of inflammation? Ann Surg (1996) 2.24
Immunopathologic alterations in murine models of sepsis of increasing severity. Infect Immun (1999) 2.13
Increased C5a receptor expression in sepsis. J Clin Invest (2002) 1.79
Circulating interleukin-6 mediates the febrile response to localised inflammation in rats. J Physiol (2000) 1.75
Clinical significance of interleukin-6 (IL-6) gene polymorphism and IL-6 serum level in pancreatic adenocarcinoma and chronic pancreatitis. Dig Dis Sci (2008) 1.65
Clinical review: immunodepression in the surgical patient and increased susceptibility to infection. Crit Care (2002) 1.54
Cytokines in sepsis: potent immunoregulators and potential therapeutic targets--an updated view. Mediators Inflamm (2013) 1.54
Coenzyme Q10 levels are low and associated with increased mortality in post-cardiac arrest patients. Resuscitation (2012) 1.47
Circulating interleukin 6 and interleukin 10 in community acquired pneumonia. Thorax (1999) 1.41
The protective effect of amiodarone in lung tissue of cecal ligation and puncture-induced septic rats: a perspective from inflammatory cytokine release and oxidative stress. Naunyn Schmiedebergs Arch Pharmacol (2013) 1.41
Elevated levels of macrophage inflammatory protein 2 in severe murine peritonitis increase neutrophil recruitment and mortality. Infect Immun (1997) 1.39
Efficacy of bacteriophage therapy against gut-derived sepsis caused by Pseudomonas aeruginosa in mice. Antimicrob Agents Chemother (2006) 1.37
Marked elevation of serum interleukin-6 in patients with cholangiocarcinoma: validation of utility as a clinical marker. Ann Surg (1998) 1.32
Effect of preoperative abstinence on poor postoperative outcome in alcohol misusers: randomised controlled trial. BMJ (1999) 1.29
Sepsis: Something old, something new, and a systems view. J Crit Care (2011) 1.29
Interleukin-6 is a potential biomarker for severe pandemic H1N1 influenza A infection. PLoS One (2012) 1.23
Time course of cytokine levels in sepsis. Intensive Care Med (1995) 1.22
Disruption of Nrf2 enhances upregulation of nuclear factor-kappaB activity, proinflammatory cytokines, and intercellular adhesion molecule-1 in the brain after traumatic brain injury. Mediators Inflamm (2009) 1.22
Biomarker and drug-target discovery using proteomics in a new rat model of sepsis-induced acute renal failure. Kidney Int (2006) 1.21
The Sick and the Weak: Neuropathies/Myopathies in the Critically Ill. Physiol Rev (2015) 1.20
Redox regulation of tumor necrosis factor signaling. Antioxid Redox Signal (2009) 1.18
Systemic inflammatory response syndrome and multiple organ dysfunction in patients with acute tumor lysis syndrome. Clinics (Sao Paulo) (2009) 1.13
Nod1 and nod2 are expressed in human and murine renal tubular epithelial cells and participate in renal ischemia reperfusion injury. J Immunol (2010) 1.13
Stress response to hepatectomy in patients with a healthy or a diseased liver. World J Surg (2003) 1.10
Scavenger receptor class a plays a central role in mediating mortality and the development of the pro-inflammatory phenotype in polymicrobial sepsis. PLoS Pathog (2012) 1.10
Clinical sepsis and septic shock--definition, diagnosis and management principles. Langenbecks Arch Surg (2008) 1.08
Regulatory effects of interleukin-6 in immunoglobulin G immune-complex-induced lung injury. Am J Pathol (1997) 1.07
An adequately robust early TNF-alpha response is a hallmark of survival following trauma/hemorrhage. PLoS One (2009) 1.05
Circulating inflammatory mediators in patients with fever: predicting bloodstream infection. Clin Diagn Lab Immunol (2001) 0.99
In vivo platelet activation in critically ill patients with primary 2009 influenza A(H1N1). Chest (2012) 0.98
Inflammation-induced recombinant protein expression in vivo using promoters from acute-phase protein genes. Proc Natl Acad Sci U S A (1995) 0.97
A clinically applicable porcine model of septic and ischemia/reperfusion-induced shock and multiple organ injury. J Surg Res (2010) 0.96
Effect of tramadol on immune responses and nociceptive thresholds in a rat model of incisional pain. J Zhejiang Univ Sci B (2008) 0.95
Potentiation by granulocyte macrophage colony-stimulating factor of lipopolysaccharide toxicity in mice. J Clin Invest (1994) 0.95
Binding of cytokines to pharmaceutically prepared human immunoglobulin. J Clin Invest (1993) 0.94
Histone deacetylase inhibitors attenuate acute lung injury during cecal ligation and puncture-induced polymicrobial sepsis. World J Surg (2010) 0.93
Is there value in plasma cytokine measurements in patients with severe trauma and sepsis? Methods (2013) 0.93
Anti-inflammatory effect of aldose reductase inhibition in murine polymicrobial sepsis. Cytokine (2009) 0.93
Anti-inflammatory mechanisms of apolipoprotein A-I mimetic peptide in acute respiratory distress syndrome secondary to sepsis. PLoS One (2013) 0.92
A murine model of mild traumatic brain injury exhibiting cognitive and motor deficits. J Surg Res (2013) 0.91
Genetically engineered superantigens as tolerable antitumor agents. Proc Natl Acad Sci U S A (1997) 0.91
Differential induction of pro- and anti-inflammatory cytokines in whole blood by bacteria: effects of antibiotic treatment. Antimicrob Agents Chemother (1997) 0.91
Presymptomatic prediction of sepsis in intensive care unit patients. Clin Vaccine Immunol (2008) 0.90
Translocation. Incidental phenomenon or true pathology? Ann Surg (1993) 0.90
Epileptogenesis due to glia-mediated synaptic scaling. J R Soc Interface (2008) 0.90
Cultured alveolar epithelial cells from septic rats mimic in vivo septic lung. PLoS One (2010) 0.89
Coenzyme Q10 levels are low and may be associated with the inflammatory cascade in septic shock. Crit Care (2011) 0.89
Time course of endothelial damage in septic shock: prediction of outcome. Crit Care (2005) 0.89
The cytoplasmic domain of tissue factor contributes to leukocyte recruitment and death in endotoxemia. Am J Pathol (2004) 0.89
Interleukin-6 modulation of intestinal epithelial tight junction permeability is mediated by JNK pathway activation of claudin-2 gene. PLoS One (2014) 0.89
Early serum procalcitonin, interleukin-6, and 24-hour lactate clearance: useful indicators of septic infections in severely traumatized patients. World J Surg (2009) 0.89
Macrophage migration inhibitory factor regulates interleukin-6 production by facilitating nuclear factor-kappa B activation during Vibrio vulnificus infection. BMC Immunol (2010) 0.88
Kinetics of tumour necrosis factor-alpha, soluble tumour necrosis factor receptors, interleukin 1-beta and its receptor antagonist during serious infections. Eur J Clin Microbiol Infect Dis (1994) 0.87
Role of endogenous interleukin-1 receptor antagonist in regulating fever induced by localised inflammation in the rat. J Physiol (2001) 0.87
Sildenafil treatment attenuates lung and kidney injury due to overproduction of oxidant activity in a rat model of sepsis: a biochemical and histopathological study. Clin Exp Immunol (2011) 0.87
Effects of Aging on Inflammation and Hemostasis through the Continuum of Critical Illness. Aging Dis (2011) 0.86
Current concept of abdominal sepsis: WSES position paper. World J Emerg Surg (2014) 0.85
Identification of murine protective epitopes on the Porphyromonas gingivalis fimbrillin molecule. Infect Immun (1996) 0.85
Ketamine suppresses intestinal NF-kappa B activation and proinflammatory cytokine in endotoxic rats. World J Gastroenterol (2004) 0.85
Inflammation-induced acute phase response in skeletal muscle and critical illness myopathy. PLoS One (2014) 0.85
Tissue- and time-dependent upregulation of cytokine mRNA in a murine model for the multiple organ dysfunction syndrome. Ann Surg (2004) 0.85
Inflammatory mediators in intra-abdominal sepsis or injury - a scoping review. Crit Care (2015) 0.84
Patterns of cytokines and soluble cellular receptors in the sera of children with acute chagas' disease. Clin Diagn Lab Immunol (2002) 0.84
Inflammatory mediators in patients receiving long-term home parenteral nutrition. Dig Dis Sci (2001) 0.84
Significant changes in the serum levels of IL-6, h-HGF, and type IV collagen 7S during the perioperative period of a hepatectomy: relevance to SIRS. Surg Today (2000) 0.84
Combination therapy versus monotherapy: a randomised pilot study on the evolution of inflammatory parameters after ventilator associated pneumonia [ISRCTN31976779]. Crit Care (2006) 0.83
Enhanced survival from CLP-induced sepsis following late administration of low doses of anti-IFNγ F(ab')2 antibody fragments. Inflamm Res (2011) 0.83
Park7 interacts with p47(phox) to direct NADPH oxidase-dependent ROS production and protect against sepsis. Cell Res (2015) 0.82
The effect of pH dependence of antibody-antigen interactions on subcellular trafficking dynamics. MAbs (2014) 0.82
Local and systemic innate immune response to secondary human peritonitis. Crit Care (2013) 0.82
Preincubation of Candida albicans strains with amphotericin B reduces tumor necrosis factor alpha and interleukin-6 release by human monocytes. Antimicrob Agents Chemother (1993) 0.82
Pro-inflammatory cytokines can act as intracellular modulators of commensal bacterial virulence. Open Biol (2013) 0.81
Hepatoprotective bioactivity of the glycoprotein, antrodan, isolated from Antrodia cinnamomea mycelia. PLoS One (2014) 0.81
Intertissue flow of glutathione (GSH) as a tumor growth-promoting mechanism: interleukin 6 induces GSH release from hepatocytes in metastatic B16 melanoma-bearing mice. J Biol Chem (2011) 0.80
Age-related differences in biomarkers of acute inflammation during hospitalization for sepsis. Shock (2014) 0.80
Effect of antiflagellar human monoclonal antibody on gut-derived Pseudomonas aeruginosa sepsis in mice. Clin Diagn Lab Immunol (1999) 0.80
Prospective randomized study of the benefits of preoperative corticosteroid administration on hepatic ischemia-reperfusion injury and cytokine response in patients undergoing hepatic resection. HPB (Oxford) (2007) 0.80
Sepsis enhances epithelial permeability with stretch in an actin dependent manner. PLoS One (2012) 0.80
Reduced perioperative immune response in video-assisted versus open surgery in a rat model. Surg Today (2009) 0.80
Adrenaline suppression of the macrophage nitric oxide response to lipopolysaccharide is associated with differential regulation of tumour necrosis factor-alpha and interleukin-10. Immunology (2001) 0.79
The soluble tumor necrosis factor receptor I is an early predictor of local infective complications after colorectal surgery. J Clin Immunol (2002) 0.79
Cytokine responses to Staphylococcus aureus bloodstream infection differ between patient cohorts that have different clinical courses of infection. BMC Infect Dis (2014) 0.78
What is the role of renin inhibition during rat septic conditions: preventive effect of aliskiren on sepsis-induced lung injury. Naunyn Schmiedebergs Arch Pharmacol (2014) 0.78
A key regulatory role for Vav1 in controlling lipopolysaccharide endotoxemia via macrophage-derived IL-6. J Immunol (2014) 0.78
Febrile response induced by cecal ligation and puncture (CLP) in rats: involvement of prostaglandin E2 and cytokines. Med Microbiol Immunol (2011) 0.78
Rho kinase regulates induction of T-cell immune dysfunction in abdominal sepsis. Infect Immun (2013) 0.78
Elevated levels of numerous cytokines in drainage fluid after primary total hip arthroplasty. Int Orthop (2009) 0.78
Peritoneal macrophages show increased cytokine gene expression following haemorrhagic shock. Immunology (1994) 0.78
Resistance to Yersinia pestis infection decreases with age in B10.T(6R) mice. Infect Immun (2011) 0.77
Interaction of hemorrhagic shock and subsequent polymicrobial sepsis on gastrointestinal motility. Shock (2009) 0.77
LPS-treated macrophage cytokines repress surfactant protein-B in lung epithelial cells. Am J Respir Cell Mol Biol (2013) 0.77
Beneficial effects of ulinastatin on gut barrier function in sepsis. Indian J Med Res (2013) 0.77
Opioid Exacerbation of Gram-positive sepsis, induced by Gut Microbial Modulation, is Rescued by IL-17A Neutralization. Sci Rep (2015) 0.77
Short-term glutamine supplementation decreases lung inflammation and the receptor for advanced glycation end-products expression in direct acute lung injury in mice. BMC Pulm Med (2014) 0.76
Src Family Kinases Modulate the Loss of Endothelial Barrier Function in Response to TNF-α: Crosstalk with p38 Signaling. PLoS One (2016) 0.76
Redox responses in patients with sepsis: high correlation of thioredoxin-1 and macrophage migration inhibitory factor plasma levels. Mediators Inflamm (2010) 0.76
Leukocyte function-associated antigen-1 deficiency impairs responses to polymicrobial sepsis. World J Clin Cases (2015) 0.76
APACHE II: a severity of disease classification system. Crit Care Med (1985) 69.83
Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science (1985) 19.41
Shock and tissue injury induced by recombinant human cachectin. Science (1986) 16.24
Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature (1988) 13.42
Cachectin: more than a tumor necrosis factor. N Engl J Med (1987) 8.74
Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med (1988) 7.96
Interleukin-6: an overview. Annu Rev Immunol (1990) 7.48
Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet (1987) 7.24
The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome. J Exp Med (1989) 6.99
Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition. J Clin Invest (1988) 5.22
Participation of tumor necrosis factor in the mediation of gram negative bacterial lipopolysaccharide-induced injury in rabbits. J Clin Invest (1988) 4.76
Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura. N Engl J Med (1988) 4.69
Interleukin-1 receptor antagonist reduces mortality from endotoxin shock. Nature (1990) 4.46
Increased plasma levels of interleukin-6 in sepsis. Blood (1989) 3.92
Functional discrimination between interleukin 6 and interleukin 1. Eur J Immunol (1988) 3.51
Cytokine appearance in human endotoxemia and primate bacteremia. Surg Gynecol Obstet (1988) 3.30
Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever. J Infect Dis (1990) 3.20
Endotoxemia elicits increased circulating beta 2-IFN/IL-6 in man. J Immunol (1989) 3.03
Lymphokines. N Engl J Med (1987) 2.77
A specific receptor antagonist for interleukin 1 prevents Escherichia coli-induced shock in rabbits. FASEB J (1991) 2.52
Serum levels of interleukin-6 and acute phase responses. Lancet (1987) 2.44
Prognostic values of tumor necrosis factor/cachectin, interleukin-1, interferon-alpha, and interferon-gamma in the serum of patients with septic shock. Swiss-Dutch J5 Immunoglobulin Study Group. J Infect Dis (1990) 2.36
Interleukin 6 (IL-6) in serum and urine of renal transplant recipients. Clin Exp Immunol (1988) 2.24
Tumor necrosis factor mediates endotoxic effects in mice. Infect Immun (1987) 2.10
Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans. Crit Care Med (1989) 1.83
Serum levels of interleukin 6, a potent myeloma cell growth factor, as a reflect of disease severity in plasma cell dyscrasias. J Clin Invest (1989) 1.72
Serum cachectin/tumor necrosis factor in critically ill patients with burns correlates with infection and mortality. Surg Gynecol Obstet (1990) 1.50
Plasma tumor necrosis factor in patients with septic shock. Mortality rate, incidence of adult respiratory distress syndrome, and effects of methylprednisolone administration. Am Rev Respir Dis (1990) 1.46
The serum interleukin 6 response to elective surgery. Lymphokine Res (1989) 1.21
The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med (1994) 27.68
Metabolic and respiratory changes after cholecystectomy performed via laparotomy or laparoscopy. Br J Anaesth (1992) 3.50
Report of the American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes and clinical trial coordination. The Consensus Committee. Intensive Care Med (1994) 3.21
Newborns develop a Th1-type immune response to Mycobacterium bovis bacillus Calmette-Guérin vaccination. J Immunol (1999) 2.94
[Thanatophoric dwarfism]. Presse Med (1967) 2.25
Voluntary brain processing in disorders of consciousness. Neurology (2008) 2.24
Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans. Clin Exp Immunol (1998) 2.20
Antithrombin III in patients with severe sepsis. A randomized, placebo-controlled, double-blind multicenter trial plus a meta-analysis on all randomized, placebo-controlled, double-blind trials with antithrombin III in severe sepsis. Intensive Care Med (1998) 2.12
Report of the American-European Consensus conference on acute respiratory distress syndrome: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Consensus Committee. J Crit Care (1994) 2.07
Interleukin-10 production during septicaemia. Lancet (1994) 2.05
Polymorphism of protein and polypeptide hormones. Clin Endocrinol (Oxf) (1972) 1.93
Pain after laparoscopic cholecystectomy: characteristics and effect of intraperitoneal bupivacaine. Anesth Analg (1995) 1.92
Interleukin-10 controls interferon-gamma and tumor necrosis factor production during experimental endotoxemia. Eur J Immunol (1994) 1.92
Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans. Crit Care Med (1989) 1.83
Functional connectivity in the default network during resting state is preserved in a vegetative but not in a brain dead patient. Hum Brain Mapp (2009) 1.72
Cortical processing of noxious somatosensory stimuli in the persistent vegetative state. Neuroimage (2002) 1.71
The American-European Consensus Conference on ARDS, part 2: Ventilatory, pharmacologic, supportive therapy, study design strategies, and issues related to recovery and remodeling. Acute respiratory distress syndrome. Am J Respir Crit Care Med (1998) 1.71
Acquired immunodeficiency syndrome in African patients. N Engl J Med (1984) 1.70
Sepsis and serum cytokine concentrations. Crit Care Med (1997) 1.63
High-dose aprotinin reduces blood loss in patients undergoing total hip replacement surgery. Anesthesiology (1994) 1.60
Restoration of thalamocortical connectivity after recovery from persistent vegetative state. Lancet (2000) 1.59
In vivo cell activation following OKT3 administration. Systemic cytokine release and modulation by corticosteroids. Transplantation (1990) 1.53
Postoperative spirometry after laparoscopy for lower abdominal or upper abdominal surgical procedures. Br J Anaesth (1997) 1.48
Epstein-Barr virus serology and Epstein-Barr virus-associated lymphoproliferative disorders in pediatric liver transplant recipients. Transplantation (1993) 1.47
Occupational stress and burnout in anaesthesia. Br J Anaesth (2003) 1.46
Acute biochemical variations induced by four different calcium salts in healthy male volunteers. Osteoporos Int (1993) 1.46
Cerebral subarachnoid blood migration consecutive to a lumbar haematoma after spinal anaesthesia. Acta Anaesthesiol Scand (2008) 1.45
Guidelines for the transfusion of red cells. Acta Clin Belg (2009) 1.41
Euthanasia: a law in Belgium? Intensive Care Med (2001) 1.38
Radio-immunoassay of casein in the serum of normal subjects and of patients with various malignancies. Eur J Cancer (1974) 1.38
In vitro assays of chondrocyte functions: the influence of drugs and hormones. Scand J Rheumatol Suppl (1990) 1.38
Laryngeal mask. Intensive Care World (1993) 1.37
Systemic reaction to the anti-T-cell monoclonal antibody OKT3 in relation to serum levels of tumor necrosis factor and interferon-gamma [corrected]. N Engl J Med (1989) 1.34
Neural mechanisms of antinociceptive effects of hypnosis. Anesthesiology (2000) 1.32
The American-European Consensus Conference on ARDS, part 2. Ventilatory, pharmacologic, supportive therapy, study design strategies and issues related to recovery and remodeling. Intensive Care Med (1998) 1.32
Increased production of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 by inflamed mucosa in inflammatory bowel disease. Clin Exp Immunol (2000) 1.30
Auditory processing in the vegetative state. Brain (2000) 1.28
Human dendritic cell responses to lipopolysaccharide and CD40 ligation are differentially regulated by interleukin-10. Eur J Immunol (1997) 1.27
Interleukin-10 prevents the generation of dendritic cells from human peripheral blood mononuclear cells cultured with interleukin-4 and granulocyte/macrophage-colony-stimulating factor. Eur J Immunol (1997) 1.24
Relationship between plasma carcinoembryonic antigen and prognosis in women with breast cancer. Eur J Cancer (1975) 1.24
Diagnostic and prognostic use of bispectral index in coma, vegetative state and related disorders. Brain Inj (2008) 1.21
1-Year controlled randomised trial of prevention of early postmenopausal bone loss by intranasal calcitonin. Lancet (1987) 1.21
The effect of hypothalamic luteinizing hormone releasing hormone (LH-RH) on plasma gonadotrophin levels in normal subjects. Clin Endocrinol (Oxf) (1974) 1.20
High levels of sTNFR p75 and TNF alpha in dengue-infected patients. Microbiol Immunol (1996) 1.19
Stimulation of proteoglycan production by glucosamine sulfate in chondrocytes isolated from human osteoarthritic articular cartilage in vitro. Osteoarthritis Cartilage (1998) 1.19
Human calcitonin radioimmunoassay in normal and pathological conditions. Eur J Clin Invest (1974) 1.18
The effect of danazol on anterior pituitary function. Fertil Steril (1977) 1.17
Soluble tumor necrosis factor receptors in chronic hepatitis C: a correlation with histological fibrosis and activity. J Hepatol (1999) 1.15
Operative mortality following surgery for colorectal cancer. Br J Surg (1989) 1.13
Inhibin: from concept to reality. Vitam Horm (1979) 1.13
Bone mineral content and physical activity. Int J Sports Med (1987) 1.09
Clonidine and ketanserin both are effective treatment for postanesthetic shivering. Anesthesiology (1993) 1.09
Direct stimulation of cytokines (IL-1 beta, TNF-alpha, IL-6, IL-2, IFN-gamma and GM-CSF) in whole blood: II. Application to rheumatoid arthritis and osteoarthritis. Cytokine (1992) 1.06
Homologous radioimmunoassay for human prolactin. Int J Nucl Med Biol (1976) 1.06
Prevention of postmenopausal bone loss by tiludronate. Lancet (1990) 1.05
Matrix metalloproteinase-3 serum levels are correlated with disease activity and predict clinical response in rheumatoid arthritis. J Rheumatol (2000) 1.05
Effects of training on exercise-induced muscle damage and interleukin 6 production. Muscle Nerve (1999) 1.05
Mild endotoxaemia and the inflammatory response induced by a marathon race. Clin Sci (Lond) (1997) 1.04
Are similar inflammatory factors involved in strenuous exercise and sepsis? Intensive Care Med (1994) 1.04
Immunohistochemical demonstration of placental alkaline phosphatase in various states of testicular development and in germ cell tumours. Int J Androl (1987) 1.04
Pathologic features and mechanisms of hypoxemia in adult respiratory distress syndrome. Am Rev Respir Dis (1976) 1.03
Clinical and biological significance of interleukin-10 plasma levels in patients with septic shock. J Clin Immunol (1995) 1.02
Attitudes towards end-of-life issues in disorders of consciousness: a European survey. J Neurol (2011) 1.01
Achondroplasia in man and animals. Clin Orthop Relat Res (1968) 1.01
Psychological approaches during conscious sedation. Hypnosis versus stress reducing strategies: a prospective randomized study. Pain (1997) 1.00
Increase in cytokine production (IL-1 beta, IL-6, TNF-alpha but not IFN-gamma, GM-CSF or LIF) by stimulated whole blood cells in postmenopausal osteoporosis. Maturitas (1997) 1.00
Radioimmunoassay of proteoglycans. J Immunoassay (1984) 1.00
Pulmonary pathology in acute respiratory insufficiency: lung biopsy as a diagnostic tool. J Thorac Cardiovasc Surg (1976) 0.99
Cytotoxicity towards human endothelial cells, induced by neutrophil myeloperoxidase: protection by ceftazidime. Mediators Inflamm (1995) 0.99
Functional neuroanatomy of hypnotic state. Biol Psychiatry (1999) 0.99
Changes in the serum levels of the gonadotrophins progesterone and estradiol during the estrous cycle of the guinea pig. Neuroendocrinology (1975) 0.98
[Dosage of prolactin in normal and pathological subjects (author's transl)]. Ann Endocrinol (Paris) (1977) 0.98
[Diagnosis of chondrodystrophic dwarfism in the newborn]. Arch Fr Pediatr (1968) 0.98
[Sequelae of Silverman's syndrome. (Multiple fractures in the infant, so-called "battered-child" syndrome). Study of 16 cases]. Presse Med (1967) 0.98
[Hurler's pseudo-polydystrophy]. Presse Med (1966) 0.97
New approaches and old controversies to postoperative pain control following cardiac surgery. Eur J Anaesthesiol (2006) 0.97
Role of defective monocyte interleukin-10 release in tumor necrosis factor-alpha overproduction in alcoholics cirrhosis. Hepatology (1995) 0.97
The neuroendocrine thymus: coexistence of oxytocin and neurophysin in the human thymus. Science (1986) 0.96
Myocellular enzyme leakage, polymorphonuclear neutrophil activation and delayed onset muscle soreness induced by isokinetic eccentric exercise. Arch Physiol Biochem (1996) 0.96
Functional MRI of sustained attention in bipolar mania. Mol Psychiatry (2010) 0.96
Different beliefs about pain perception in the vegetative and minimally conscious states: a European survey of medical and paramedical professionals. Prog Brain Res (2009) 0.95
Red blood cell substitutes: fluorocarbon emulsions and haemoglobin solutions. Br Med Bull (1999) 0.95
[Studies of gonadal function in patients with central diabetes insipidus (author's transl)]. J Neurovisc Relat (1971) 0.95
Relationship between spermatogenesis and serum gonadotropin levels in azoospermia and oligospermia. J Clin Endocrinol Metab (1972) 0.95
Measurement of proteoglycans, elastase, collagenase and protein in synovial fluid in inflammatory and degenerative arthropathies. Clin Rheumatol (1985) 0.95
Epidural anesthesia impairs both central and peripheral thermoregulatory control during general anesthesia. Anesthesiology (1994) 0.95
In vitro inhibition of tumour necrosis factor-alpha and interleukin-6 production by intravenous immunoglobulins. Br J Haematol (1995) 0.95
Active oxygen species, articular inflammation and cartilage damage. EXS (1992) 0.94
Pain and non-pain processing during hypnosis: a thulium-YAG event-related fMRI study. Neuroimage (2009) 0.93